Advertisement
Canada markets open in 1 hour 27 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7323
    0.0000 (-0.00%)
     

  • CRUDE OIL

    84.09
    +0.52 (+0.62%)
     

  • Bitcoin CAD

    87,619.67
    +520.47 (+0.60%)
     

  • CMC Crypto 200

    1,385.02
    -11.52 (-0.83%)
     

  • GOLD FUTURES

    2,355.90
    +13.40 (+0.57%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,750.00
    +182.50 (+1.04%)
     

  • VOLATILITY

    15.61
    +0.24 (+1.56%)
     

  • FTSE

    8,116.24
    +37.38 (+0.46%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6830
    +0.0009 (+0.13%)
     

Company News for Jun 29, 2020

Zacks Equity Research
·1 min read

  • Shares of The Gap, Inc. GPS jumped 18.8% after the company reported that it has partnered with Kanye West's Yeezy brand.

  • Shares of CoreLogic, Inc. CLGX soared 28.4% after the company reported that Cannae Holdings and Senator Investment Group submitted a proposal to acquire CoreLogic for $65 per share in cash.

  • Shares of Axsome Therapeutics, Inc. AXSM rose nearly 12% after the company announced it has received FDA breakthrough therapy designation for AXS-05 for the treatment of Alzheimer's disease agitation.

  • Shares of Vaxart, Inc. VXRT jumped 28.4% after the company's coronavirus vaccine was selected for the US Government's Operation Warp Speed.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
The Gap, Inc. (GPS) : Free Stock Analysis Report
 
CoreLogic, Inc. (CLGX) : Free Stock Analysis Report
 
Axsome Therapeutics, Inc. (AXSM) : Free Stock Analysis Report
 
VAXART, INC. (VXRT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research